1994
DOI: 10.1016/0014-5793(94)00917-1
|View full text |Cite
|
Sign up to set email alerts
|

Dystroglycan is a binding protein of laminin and merosin in peripheral nerve

Abstract: a-Dystroglycan, a 156 kDa dystrophin-associated glycoprotein, binds laminin in skeletal muscle. Here we demonstrate that a-dystroglycan is a binding protein of laminin (AIBlIB2) and merosin (MIBlIB2) in peripheral nerve. Immunocytochemical analysis demonstrates the localization of a-dystroglycan and merosin surrounding myelin sheath of peripheral nerve fibers. Biochemical analysis demonstrates that the 120 kDa peripheral nerve a-dystroglycan binds merosin as well as laminin. The binding of laminin and merosin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
114
1

Year Published

1995
1995
2012
2012

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 141 publications
(121 citation statements)
references
References 34 publications
6
114
1
Order By: Relevance
“…Another function that involves the LG domains of agrin is the binding to ␣-dystroglycan, a peripheral membrane protein that is tightly associated with the transmembranous ␤-dystroglycan and arises from a common precursor protein by posttranslational cleavage (33). Binding to ␣-dystroglycan has also been found in other LG domain-containing proteins such as laminin-␣1 and -␣2 (33)(34)(35), perlecan (35), and neurexins (36). Although initially postulated, binding of agrin to ␣-dystroglycan is not necessary for its AChR-aggregating activity (23).…”
mentioning
confidence: 97%
“…Another function that involves the LG domains of agrin is the binding to ␣-dystroglycan, a peripheral membrane protein that is tightly associated with the transmembranous ␤-dystroglycan and arises from a common precursor protein by posttranslational cleavage (33). Binding to ␣-dystroglycan has also been found in other LG domain-containing proteins such as laminin-␣1 and -␣2 (33)(34)(35), perlecan (35), and neurexins (36). Although initially postulated, binding of agrin to ␣-dystroglycan is not necessary for its AChR-aggregating activity (23).…”
mentioning
confidence: 97%
“…␣-Dystroglycan binds with high affinity to several extracellular matrix components, laminin, agrin, and neurexin (32,(35)(36)(37)(38), and it is heavily glycosylated with O-linked mannosyl glycans (39 -43). Mutations in POMT1, POMT2, POMGnT1, and LARGE lead to altered glycosylation of ␣-dystroglycan with abolished laminin binding activity and are believed to be a major underlying mechanism of muscular dystrophy and type II lissencephaly (10, 44 -46).…”
mentioning
confidence: 99%
“…These multimolecular complexes have two major functions: 1) provide structural anchorage and adhesion by linking the actin cytoskeleton to the basal lamina; and 2) localize specific ion channels and signaling molecules to precise surface membrane regions (Matsumura et al, 1993;Yamada et al, 1994;Saito et al, 1999;Imamura et al, 2000;Masaki et al, 2001;Haenggi et al, 2004). In peripheral nerve, Dp116 and full-length utrophin provide structural support to the outer surface membrane of Schwann cells by linking the actin cytoskeleton and basal lamina (Yamada et al, 1994;Saito et al, 1999;Imamura et al, 2000;Saito et al, 2003). Demyelinating neuropathy has been seen in dystrophic patients with loss of Dp116 (Comi et al, 1995), and myelin instability occurs in animal models in which the dystrophin complex is disrupted (Saito et al, 2003;Cai et al, 2007).…”
Section: Discussionmentioning
confidence: 99%